- Home
- SCOR vs IGC Comparison
SCOR vs IGC Comparison
Compare SCOR & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCOR | IGC |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 31.2M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCOR | IGC |
|---|---|---|
| Price | $6.50 | $0.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 7.4K | ★ 979.4K |
| Earning Date | 11-04-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $358,940,000.00 | $1,106,000.00 |
| Revenue This Year | $2.01 | $3.54 |
| Revenue Next Year | $1.57 | $15.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $4.39 | $0.25 |
| 52 Week High | $10.18 | $0.50 |
Technical Indicators
Market Signals| Indicator | SCOR | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 40.42 | 31.98 |
| Support Level | $6.51 | $0.29 |
| Resistance Level | $7.00 | $0.31 |
| Average True Range (ATR) | 0.29 | 0.02 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 0.00 | 4.00 |
Price Performance
Historical ComparisonAbout SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.